Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1996 Jul;118(6):1455–1460. doi: 10.1111/j.1476-5381.1996.tb15560.x

Effects of neuropeptide Y on L-type calcium current in guinea-pig ventricular myocytes.

S M Bryant 1, G Hart 1
PMCID: PMC1909662  PMID: 8832072

Abstract

1. Neuropeptide Y (NPY) reduces cell shortening at high concentrations in guinea-pig ventricular myocytes. We have studied the effects of the peptide on calcium current in cardiac myocytes. 2. We have recorded L-type calcium current in guinea-pig ventricular myocytes under conditions in which the effects of other overlapping currents have been minimised by using Na(+)-free, K(+)-free external solution and patch-clamp electrodes containing Cs+. 3. Peak inward calcium current is reduced by NPY at concentrations in excess of 1 nM, and maximal inhibition (31%) was found at and above concentrations of 100 nM. The IC50 value for NPY inhibition of peak calcium current was 1.72 nM. 4. NPY had no effect on the voltage-dependence of calcium current amplitude, on the time course of current inactivation, or on the voltage-dependence of the steady-state gating variables. 5. NPY did not reduce the calcium current in the presence of 8-Br-cyclic AMP, and it was also without effect when GTP-gamma-S or GDP-beta-S were included in the patch pipette. 6. We conclude that in guinea-pig ventricular myocytes NPY acts at low concentration to reduce L-type calcium current, via a G-protein-mediated pathway and reduction in intracellular cyclic AMP.

Full text

PDF
1455

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen J. M., Bircham P. M., Edwards A. V., Tatemoto K., Bloom S. R. Neuropeptide Y (NPY) reduces myocardial perfusion and inhibits the force of contraction of the isolated perfused rabbit heart. Regul Pept. 1983 Jul;6(3):247–253. doi: 10.1016/0167-0115(83)90143-x. [DOI] [PubMed] [Google Scholar]
  2. Balasubramaniam A., Grupp I., Matlib M. A., Benza R., Jackson R. L., Fischer J. E., Grupp G. Comparison of the effects of neuropeptide Y (NPY) and 4-norleucine-NPY on isolated perfused rat hearts; effects of NPY on atrial and ventricular strips of rat heart and on rabbit heart mitochondria. Regul Pept. 1988 Jun;21(3-4):289–299. doi: 10.1016/0167-0115(88)90012-2. [DOI] [PubMed] [Google Scholar]
  3. Balasubramaniam A., Sheriff S., Rigel D. F., Fischer J. E. Characterization of neuropeptide Y binding sites in rat cardiac ventricular membranes. Peptides. 1990 May-Jun;11(3):545–550. doi: 10.1016/0196-9781(90)90057-c. [DOI] [PubMed] [Google Scholar]
  4. Beebe S. J., Blackmore P. F., Chrisman T. D., Corbin J. D. Use of synergistic pairs of site-selective cAMP analogs in intact cells. Methods Enzymol. 1988;159:118–139. doi: 10.1016/0076-6879(88)59013-4. [DOI] [PubMed] [Google Scholar]
  5. Belardinelli L., Shryock J. C., Song Y., Wang D., Srinivas M. Ionic basis of the electrophysiological actions of adenosine on cardiomyocytes. FASEB J. 1995 Mar;9(5):359–365. doi: 10.1096/fasebj.9.5.7896004. [DOI] [PubMed] [Google Scholar]
  6. Bryant S. M., Ryder K. O., Hart G. Effects of neuropeptide Y on cell length and membrane currents in isolated guinea pig ventricular myocytes. Circ Res. 1991 Oct;69(4):1106–1113. doi: 10.1161/01.res.69.4.1106. [DOI] [PubMed] [Google Scholar]
  7. Dalsgaard C. J., Franco-Cereceda A., Saria A., Lundberg J. M., Theodorsson-Norheim E., Hökfelt T. Distribution and origin of substance P- and neuropeptide Y-immunoreactive nerves in the guinea-pig heart. Cell Tissue Res. 1986;243(3):477–485. doi: 10.1007/BF00218054. [DOI] [PubMed] [Google Scholar]
  8. Dumont Y., Martel J. C., Fournier A., St-Pierre S., Quirion R. Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues. Prog Neurobiol. 1992;38(2):125–167. doi: 10.1016/0301-0082(92)90038-g. [DOI] [PubMed] [Google Scholar]
  9. Ewald D. A., Sternweis P. C., Miller R. J. Guanine nucleotide-binding protein Go-induced coupling of neuropeptide Y receptors to Ca2+ channels in sensory neurons. Proc Natl Acad Sci U S A. 1988 May;85(10):3633–3637. doi: 10.1073/pnas.85.10.3633. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fleming J. W., Wisler P. L., Watanabe A. M. Signal transduction by G proteins in cardiac tissues. Circulation. 1992 Feb;85(2):420–433. doi: 10.1161/01.cir.85.2.420. [DOI] [PubMed] [Google Scholar]
  11. Franco-Cereceda A., Lundberg J. M., Dahlöf C. Neuropeptide Y and sympathetic control of heart contractility and coronary vascular tone. Acta Physiol Scand. 1985 Jul;124(3):361–369. doi: 10.1111/j.1748-1716.1985.tb07671.x. [DOI] [PubMed] [Google Scholar]
  12. Hassall C. J., Burnstock G. Neuropeptide Y-like immunoreactivity in cultured intrinsic neurones of the heart. Neurosci Lett. 1984 Nov 23;52(1-2):111–115. doi: 10.1016/0304-3940(84)90359-8. [DOI] [PubMed] [Google Scholar]
  13. Isenberg G., Belardinelli L. Ionic basis for the antagonism between adenosine and isoproterenol on isolated mammalian ventricular myocytes. Circ Res. 1984 Sep;55(3):309–325. doi: 10.1161/01.res.55.3.309. [DOI] [PubMed] [Google Scholar]
  14. Kameyama M., Kameyama A., Nakayama T., Kaibara M. Tissue extract recovers cardiac calcium channels from 'run-down'. Pflugers Arch. 1988 Aug;412(3):328–330. doi: 10.1007/BF00582516. [DOI] [PubMed] [Google Scholar]
  15. Kassis S., Olasmaa M., Terenius L., Fishman P. H. Neuropeptide Y inhibits cardiac adenylate cyclase through a pertussis toxin-sensitive G protein. J Biol Chem. 1987 Mar 15;262(8):3429–3431. [PubMed] [Google Scholar]
  16. Kozlowski R. Z., Goodstadt L. J., Twist V. W., Powell T. Activation of L-type Ca2+ currents in cardiac myocytes by photoreleased GTP. Proc Biol Sci. 1992 Oct 22;250(1327):35–42. doi: 10.1098/rspb.1992.0127. [DOI] [PubMed] [Google Scholar]
  17. Maisel A. S., Scott N. A., Motulsky H. J., Michel M. C., Boublik J. H., Rivier J. E., Ziegler M., Allen R. S., Brown M. R. Elevation of plasma neuropeptide Y levels in congestive heart failure. Am J Med. 1989 Jan;86(1):43–48. doi: 10.1016/0002-9343(89)90228-3. [DOI] [PubMed] [Google Scholar]
  18. McDermott B. J., Millar B. C., Piper H. M. Cardiovascular effects of neuropeptide Y: receptor interactions and cellular mechanisms. Cardiovasc Res. 1993 Jun;27(6):893–905. doi: 10.1093/cvr/27.6.893. [DOI] [PubMed] [Google Scholar]
  19. Mewes T., Dutz S., Ravens U., Jakobs K. H. Activation of calcium currents in cardiac myocytes by empty beta-adrenoceptors. Circulation. 1993 Dec;88(6):2916–2922. doi: 10.1161/01.cir.88.6.2916. [DOI] [PubMed] [Google Scholar]
  20. Michel M. C. Receptors for neuropeptide Y: multiple subtypes and multiple second messengers. Trends Pharmacol Sci. 1991 Oct;12(10):389–394. doi: 10.1016/0165-6147(91)90610-5. [DOI] [PubMed] [Google Scholar]
  21. Millar B. C., Weis T., Piper H. M., Weber M., Borchard U., McDermott B. J., Balasubramaniam A. Positive and negative contractile effects of neuropeptide Y on ventricular cardiomyocytes. Am J Physiol. 1991 Dec;261(6 Pt 2):H1727–H1733. doi: 10.1152/ajpheart.1991.261.6.H1727. [DOI] [PubMed] [Google Scholar]
  22. Pelzmann B., Schaffer P., Mächler H., Rigler B., Koidl B. Adenosine inhibits the L-type calcium current in human atrial myocytes. Naunyn Schmiedebergs Arch Pharmacol. 1995 Mar;351(3):293–297. doi: 10.1007/BF00233249. [DOI] [PubMed] [Google Scholar]
  23. Piper H. M., Millar B. C., McDermott B. J. The negative inotropic effect of neuropeptide Y on the ventricular cardiomyocyte. Naunyn Schmiedebergs Arch Pharmacol. 1989 Sep;340(3):333–337. doi: 10.1007/BF00168519. [DOI] [PubMed] [Google Scholar]
  24. Potter E. K. Neuropeptide Y as an autonomic neurotransmitter. Pharmacol Ther. 1988;37(2):251–273. doi: 10.1016/0163-7258(88)90028-9. [DOI] [PubMed] [Google Scholar]
  25. Qu Y., Campbell D. L., Whorton A. R., Strauss H. C. Modulation of basal L-type Ca2+ current by adenosine in ferret isolated right ventricular myocytes. J Physiol. 1993 Nov;471:269–293. doi: 10.1113/jphysiol.1993.sp019901. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Ryder K. O., Bryant S. M., Hart G. Membrane current changes in left ventricular myocytes isolated from guinea pigs after abdominal aortic coarctation. Cardiovasc Res. 1993 Jul;27(7):1278–1287. doi: 10.1093/cvr/27.7.1278. [DOI] [PubMed] [Google Scholar]
  27. Sheriff S., Balasubramaniam A. Inhibitory and stimulatory effects of neuropeptide Y(17-36) on rat cardiac adenylate cyclase activity. Structure-function studies. J Biol Chem. 1992 Mar 5;267(7):4680–4685. [PubMed] [Google Scholar]
  28. Tatemoto K. Neuropeptide Y: complete amino acid sequence of the brain peptide. Proc Natl Acad Sci U S A. 1982 Sep;79(18):5485–5489. doi: 10.1073/pnas.79.18.5485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Trautwein W., Hescheler J. Regulation of cardiac L-type calcium current by phosphorylation and G proteins. Annu Rev Physiol. 1990;52:257–274. doi: 10.1146/annurev.ph.52.030190.001353. [DOI] [PubMed] [Google Scholar]
  30. Ullman B., Hulting J., Lundberg J. M. Prognostic value of plasma neuropeptide-Y in coronary care unit patients with and without acute myocardial infarction. Eur Heart J. 1994 Apr;15(4):454–461. doi: 10.1093/oxfordjournals.eurheartj.a060526. [DOI] [PubMed] [Google Scholar]
  31. Valentijn J. A., Vaudry H., Kloas W., Cazin L. Melanostatin (NPY) inhibited electrical activity in frog melanotrophs through modulation of K+, Na+ and Ca2+ currents. J Physiol. 1994 Mar 1;475(2):185–195. doi: 10.1113/jphysiol.1994.sp020060. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Wagner J. A., Weisman H. F., Snowman A. M., Reynolds I. J., Weisfeldt M. L., Snyder S. H. Alterations in calcium antagonist receptors and sodium-calcium exchange in cardiomyopathic hamster tissues. Circ Res. 1989 Jul;65(1):205–214. doi: 10.1161/01.res.65.1.205. [DOI] [PubMed] [Google Scholar]
  33. Warner M. R., Levy M. N. Inhibition of cardiac vagal effects by neurally released and exogenous neuropeptide Y. Circ Res. 1989 Dec;65(6):1536–1546. doi: 10.1161/01.res.65.6.1536. [DOI] [PubMed] [Google Scholar]
  34. Warner M. R., Levy M. N. Neuropeptide Y as a putative modulator of the vagal effects on heart rate. Circ Res. 1989 May;64(5):882–889. doi: 10.1161/01.res.64.5.882. [DOI] [PubMed] [Google Scholar]
  35. Wiley J. W., Gross R. A., MacDonald R. L. Agonists for neuropeptide Y receptor subtypes NPY-1 and NPY-2 have opposite actions on rat nodose neuron calcium currents. J Neurophysiol. 1993 Jul;70(1):324–330. doi: 10.1152/jn.1993.70.1.324. [DOI] [PubMed] [Google Scholar]
  36. Xiang H., Brown J. C. Inhibitory effect of neuropeptide Y and its analogues on inositol 1,4,5-trisphosphate level in rat cardiomyocytes. Receptors Channels. 1993;1(4):315–321. [PubMed] [Google Scholar]
  37. Xiong Z., Bolzon B. J., Cheung D. W. Neuropeptide Y potentiates calcium-channel currents in single vascular smooth muscle cells. Pflugers Arch. 1993 Jun;423(5-6):504–510. doi: 10.1007/BF00374948. [DOI] [PubMed] [Google Scholar]
  38. Zukowska-Grojec Z., Marks E. S., Haass M. Neuropeptide Y is a potent vasoconstrictor and a cardiodepressant in rat. Am J Physiol. 1987 Nov;253(5 Pt 2):H1234–H1239. doi: 10.1152/ajpheart.1987.253.5.H1234. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES